STAT+ profiled Kyle Diamantas’ rise to lead the FDA’s top food role in 2025, noting that the appointment came from outside traditional public health and scientific leadership. The piece describes Diamantas’ background as a Florida attorney and the context of internal disruption following DOGE-related layoffs and the defiant resignation of former leader Jim Jones. While the profile centers on food-industry oversight rather than therapeutics, it points to how regulatory leadership changes can ripple across agency processes and institutional priorities. For life-sciences companies, leadership turns often translate into altered engagement patterns with FDA. The story adds context to a shifting regulatory environment, with attention likely to remain on how FDA leadership navigates constraints while setting guidance and enforcement direction.